Law360, New York (January 12, 2018, 5:44 PM EST) — The Patent Trial and Appeal Board on Thursday granted Watson Laboratories Inc.’s request to review two United Therapeutics Corp. patents covering its hypertension drug Tyvaso, turning down arguments from United Therapeutics that the …
